Takasaki, S. (2021) “Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma”, Journal of Pharmacy & Pharmaceutical Sciences, 24, pp. 127–136. doi: 10.18433/jpps31816.